Table 3.
HR (95% CI) | P value | |
---|---|---|
Progression-free survival | ||
Multifocality | 1.74 (1.00–3.02) | 0.049 |
Extent of resection | ||
Gross-total vs. biopsy | 0.23 (0.13–0.42) | < 0.001 |
Subtotal vs. biopsy | 0.51 (0.29–0.90) | 0.021 |
Strong EGFR expression | 6.15 (2.15–17.60) | 0.001 |
Overall survival | ||
Extent of resection | ||
Gross-total vs. biopsy | 0.16 (0.08–0.31) | < 0.001 |
Subtotal vs. biopsy | 0.37 (0.19–0.71) | 0.03 |
WHO Grade, II vs. III | 0.35 (0.18–0.70) | 0.003 |
Strong EGFR expression | 7.33 (2.21–24.35) | 0.001 |
Perioperative complication | 2.00 (1.05–3.79) | 0.034 |
TERT mutated vs. wild-type | 13.58 (1.69–109.04) | 0.014 |
Multivariate Cox Proportional Hazards Regression analysis, backward conditional selection method used, step 6 is displayed for PFS and step 4 for OS.